PortalPublikationenOutcome of allogeneic haematopoietic stem cell transplantati...

Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable

Standard

Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable : a retrospective study by the Chronic Malignancies Working Party of the EBMT. / McLornan, Donal P; Malpassuti, Vittoria; Lippinkhof-Kozijn, Anne; Potter, Victoria; Beelen, Dietrich; Bunjes, Donald; Sengeloev, Henrik; Radujkovic, Aleksandar; Passweg, Jakob; Chalandon, Yves; Kröger, Nicolaus; Wulf, Gerald G; Johansson, Jan-Erik; Ciceri, Fabio; Bornhäuser, Martin; Holler, Ernst; Guffroy, Blandine; Martin, Sonja; Neubauer, Andreas; Gramatski, Martin; Robin, Marie; Iacobelli, Simona; Hayden, Patrick; Hernández Boluda, Juan C; Czerw, Tomasz; Yakoub-Agha, Ibrahim.

in: BRIT J HAEMATOL, Jahrgang 190, Nr. 3, 08.2020, S. 437-441.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

McLornan, DP, Malpassuti, V, Lippinkhof-Kozijn, A, Potter, V, Beelen, D, Bunjes, D, Sengeloev, H, Radujkovic, A, Passweg, J, Chalandon, Y, Kröger, N, Wulf, GG, Johansson, J-E, Ciceri, F, Bornhäuser, M, Holler, E, Guffroy, B, Martin, S, Neubauer, A, Gramatski, M, Robin, M, Iacobelli, S, Hayden, P, Hernández Boluda, JC, Czerw, T & Yakoub-Agha, I 2020, 'Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT', BRIT J HAEMATOL, Jg. 190, Nr. 3, S. 437-441. https://doi.org/10.1111/bjh.16537

APA

McLornan, D. P., Malpassuti, V., Lippinkhof-Kozijn, A., Potter, V., Beelen, D., Bunjes, D., Sengeloev, H., Radujkovic, A., Passweg, J., Chalandon, Y., Kröger, N., Wulf, G. G., Johansson, J-E., Ciceri, F., Bornhäuser, M., Holler, E., Guffroy, B., Martin, S., Neubauer, A., ... Yakoub-Agha, I. (2020). Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT. BRIT J HAEMATOL, 190(3), 437-441. https://doi.org/10.1111/bjh.16537

Vancouver

McLornan DP, Malpassuti V, Lippinkhof-Kozijn A, Potter V, Beelen D, Bunjes D et al. Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT. BRIT J HAEMATOL. 2020 Aug;190(3):437-441. https://doi.org/10.1111/bjh.16537

Bibtex

@article{512ac6578d77462b860489817c1402cd,
title = "Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT",
abstract = "Myeloproliferative Neoplasm (MPN), unclassifiable (MPN-U) is a heterogeneous disease with regards to both clinical phenotype and disease course. Patients may initially be asymptomatic or present with leucocytosis or thrombocytosis, anaemia, progressive splenomegaly, constitutional symptom, thromboses or accelerated/blastic phase disease. Treatment strategies are variable and there are no widely accepted consensus management guidelines for MNU-U. Allogeneic Haematopoietic Cell Transplantation (allo-HCT) remains the only curative strategy yet outcomes, to date, are not well defined. We hereby report on the largest retrospective study of patients with MPN-U undergoing allo-HCT, highlighting the potentially curative role and providing clinicians with robust engraftment, GvHD and outcome data to facilitate patient discussion.",
author = "McLornan, {Donal P} and Vittoria Malpassuti and Anne Lippinkhof-Kozijn and Victoria Potter and Dietrich Beelen and Donald Bunjes and Henrik Sengeloev and Aleksandar Radujkovic and Jakob Passweg and Yves Chalandon and Nicolaus Kr{\"o}ger and Wulf, {Gerald G} and Jan-Erik Johansson and Fabio Ciceri and Martin Bornh{\"a}user and Ernst Holler and Blandine Guffroy and Sonja Martin and Andreas Neubauer and Martin Gramatski and Marie Robin and Simona Iacobelli and Patrick Hayden and {Hern{\'a}ndez Boluda}, {Juan C} and Tomasz Czerw and Ibrahim Yakoub-Agha",
note = "{\textcopyright} 2020 British Society for Haematology and John Wiley & Sons Ltd.",
year = "2020",
month = aug,
doi = "10.1111/bjh.16537",
language = "English",
volume = "190",
pages = "437--441",
journal = "BRIT J HAEMATOL",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable

T2 - a retrospective study by the Chronic Malignancies Working Party of the EBMT

AU - McLornan, Donal P

AU - Malpassuti, Vittoria

AU - Lippinkhof-Kozijn, Anne

AU - Potter, Victoria

AU - Beelen, Dietrich

AU - Bunjes, Donald

AU - Sengeloev, Henrik

AU - Radujkovic, Aleksandar

AU - Passweg, Jakob

AU - Chalandon, Yves

AU - Kröger, Nicolaus

AU - Wulf, Gerald G

AU - Johansson, Jan-Erik

AU - Ciceri, Fabio

AU - Bornhäuser, Martin

AU - Holler, Ernst

AU - Guffroy, Blandine

AU - Martin, Sonja

AU - Neubauer, Andreas

AU - Gramatski, Martin

AU - Robin, Marie

AU - Iacobelli, Simona

AU - Hayden, Patrick

AU - Hernández Boluda, Juan C

AU - Czerw, Tomasz

AU - Yakoub-Agha, Ibrahim

N1 - © 2020 British Society for Haematology and John Wiley & Sons Ltd.

PY - 2020/8

Y1 - 2020/8

N2 - Myeloproliferative Neoplasm (MPN), unclassifiable (MPN-U) is a heterogeneous disease with regards to both clinical phenotype and disease course. Patients may initially be asymptomatic or present with leucocytosis or thrombocytosis, anaemia, progressive splenomegaly, constitutional symptom, thromboses or accelerated/blastic phase disease. Treatment strategies are variable and there are no widely accepted consensus management guidelines for MNU-U. Allogeneic Haematopoietic Cell Transplantation (allo-HCT) remains the only curative strategy yet outcomes, to date, are not well defined. We hereby report on the largest retrospective study of patients with MPN-U undergoing allo-HCT, highlighting the potentially curative role and providing clinicians with robust engraftment, GvHD and outcome data to facilitate patient discussion.

AB - Myeloproliferative Neoplasm (MPN), unclassifiable (MPN-U) is a heterogeneous disease with regards to both clinical phenotype and disease course. Patients may initially be asymptomatic or present with leucocytosis or thrombocytosis, anaemia, progressive splenomegaly, constitutional symptom, thromboses or accelerated/blastic phase disease. Treatment strategies are variable and there are no widely accepted consensus management guidelines for MNU-U. Allogeneic Haematopoietic Cell Transplantation (allo-HCT) remains the only curative strategy yet outcomes, to date, are not well defined. We hereby report on the largest retrospective study of patients with MPN-U undergoing allo-HCT, highlighting the potentially curative role and providing clinicians with robust engraftment, GvHD and outcome data to facilitate patient discussion.

U2 - 10.1111/bjh.16537

DO - 10.1111/bjh.16537

M3 - SCORING: Journal article

C2 - 32108327

VL - 190

SP - 437

EP - 441

JO - BRIT J HAEMATOL

JF - BRIT J HAEMATOL

SN - 0007-1048

IS - 3

ER -